Cardiovascular Assessment in Patient Recovered From COVID-19 and Recovery of Autonomic Nervous System in Association With the Severity of the Disease
COVIDans
1 other identifier
interventional
67
1 country
1
Brief Summary
The goal of the study is to assess autonomic nervous system and cardiovascular controll during orthostatic challenge in 90 patients recovered from COVID-19 and devided into three groups depend on severity of the morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Oct 2021
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2021
CompletedFirst Posted
Study publicly available on registry
October 18, 2021
CompletedStudy Start
First participant enrolled
October 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2022
CompletedJanuary 25, 2023
January 1, 2023
1.1 years
October 7, 2021
January 23, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Arterial pressure measured in mmHg
Continuous measurement of the arterial pressure for 10 minutes in rest and 10 minutes in orthostatic position.
6 months
Heart rate measured in bpm
Continuous measurement of heart rate for 10 minutes in rest and 10 minutes in orthostatic position.
6 months
Respiratory frequency
Continuous measurement of respiratory frequency for 10 minutes in rest and 10 minutes in orthostatic position.
6 months
Study Arms (3)
COVID-severe
OTHERpatient recovered from severe COVID desease
COVID-moderate
OTHERpatient recovered from moderate COVID desease
COVID-mild
OTHERpatient recovered from mild COVID desease
Interventions
Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position
Eligibility Criteria
You may qualify if:
- age over 18
- spontaneous sinus rhythm
- signed informed consent
You may not qualify if:
- no spontaneous sinus rhythm
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Milano, 20097, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of cardiovascular anesthesiology and intensive care
Study Record Dates
First Submitted
October 7, 2021
First Posted
October 18, 2021
Study Start
October 18, 2021
Primary Completion
November 9, 2022
Study Completion
November 9, 2022
Last Updated
January 25, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share